The dysfunctional ERs in the ER+PgR− phenotype showed slower rates of tissue invasion, suggesting that ligand binding to functional breast tumor ERs, beside promoting the PgR expression, possibly also promotes tumor transition to the invasive phase. The gene discussed is PGR; the disease is breast neoplasm.